Eyenovia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEyenovia

Eyenovia(EYEN)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Mydcombi	Phenylephrine, Tropicamide	2023-05-05	2031-2036	Septic shock , Hypotension , Pruritus ani , Pain , Postoperative pain , Open-angle glaucoma , Fissure in ano , Intraocular lens implantation , Hemorrhoids , Vasomotor rhinitis , Supraventricular tachycardia , Juvenile arthritis , Menorrhagia , Ankylosing spondylitis , Rheumatoid arthritis , Fever , Inflammation , Osteoarthritis , Bursitis , Dysmenorrhea , Gout , Premenstrual syndrome , Allergic rhinitis perennial , Urticaria , Photophobia , Allergic conjunctivitis , Low cardiac output , Bradycardia , Heart arrest , Ventricular fibrillation , Hemorrhagic shock , Torsades de pointes , Adams-stokes syndrome , Pruritus , Allergic rhinitis seasonal , Postoperative complications , Vomiting , Nausea , Anaphylaxis , Cough , Motion sickness , Keratitis , Iritis , Iridocyclitis
Clobetasol	Clobetasol	2024-03-04	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

diabetic retinopathy

,

retinitis pigmentosa

,

,

autonomic nervous system diseases

,

,

orthostatic hypotension

,

nervous system diseases

,

primary dysautonomias

,

orthostatic intolerance

,

penetrating keratoplasty

,

,

,

parkinson disease

,

,

,

anterior uveitis

,

,

corneal endothelial cell loss

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

type 1 diabetes mellitus

,

,

,

retinal diseases

,

retinopathy of prematurity

,

premature birth

,

,

refractive errors

,

pathologic dilatation

,

intraocular pressure

,

,

dry eye syndromes

,

corneal transplantation

,

,

,

meibomian gland dysfunction

,

vision disorders

,

,

pupil disorders

,

,

,

,

open-angle glaucoma

,

macular degeneration

,

,

,

,

,

,

marfan syndrome

,

,

,

,

epiretinal membrane

,

,

central serous chorioretinopathy

,

exfoliation syndrome

,

phacoemulsification

,

,

chromosome aberrations

,

retinal detachment

,

cataract extraction

,

drug-related side effects and adverse reactions

,

newborn infant diseases

,

,

keratoconjunctivitis sicca

,

,

vestibular diseases

,

,

cognitive dysfunction

,

parkinsonian disorders

,

healthy volunteers/patients

,

retinal vein occlusion

,

cognitive dysfunction

,

allergic rhinitis

,

,

general anesthesia

,

,

male genital neoplasms

,

allergic rhinitis seasonal

,

allergic rhinitis perennial

,

replacement arthroplasty knee

,

replacement arthroplasty hip

,

,

blood coagulation

,

neuromuscular blockade

,

delayed emergence from anesthesia

,

postoperative nausea and vomiting

,

,

,

cognitive dysfunction

,

allergic rhinitis

,

,

general anesthesia

,

,

male genital neoplasms

,

allergic rhinitis seasonal

,

allergic rhinitis perennial

,

replacement arthroplasty knee

,

replacement arthroplasty hip

,

,

blood coagulation

,

neuromuscular blockade

,

delayed emergence from anesthesia

,

postoperative nausea and vomiting

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use